ESLAW vs LDOS
Estrella Immunopharma Inc. (ESLAW) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
ESLAW does not have a complete income-statement cache yet.
Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
ESLAW currently screens at market cap $0. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the ESLAW and LDOS stock pages for the full models.
Not investment advice.